Renalytix Share Discussion Threads

[74tom] 16/9/2021 10:29

Added a few more at 615p, still the sells arrive… intrigued as to where the bottom is now, considering the Mount Sinai news on Tuesday this is becoming better value by the minute.

[nimbo1] 16/9/2021 10:17

unless they do something news worthy I see verici back near the placing price or closer to 40p by the time the divi shares are unlocked... assume mills will absorb all the selling come November?

[toffeeman] 16/9/2021 10:11

Verici getting caned now so maybe it's not shorting - mistimed my entry!

[74tom] 15/9/2021 12:21

Haha, it was indeed - JM is obviously a fan ;)

[homebrewruss] 15/9/2021 12:02

"if you can make it in New York you can make it anywhere".

I thought that was Frank Sinatra? :)

[mr roper] 15/9/2021 11:59

Added today. Will be adding more as funds allow.

[74tom] 15/9/2021 11:25

For sure. I must admit I wasn't comfortable holding at the £11 level once the rising uptrend had been broken in July. It just felt like the market would look for any opportunity to hammer the price back down, similar to Q420 when we retested £4.

The nice thing now is that the transition to a significant revenue generating company is well underway, whereas this time last year implementation at Sinai had only just started. As JM says in the Wells Fargo, "if you can make it in New York you can make it anywhere".

[toffeeman] 15/9/2021 11:11

>> longshanks

Hi :)

[longshanks] 15/9/2021 10:24

Bought a few more myself. I note that RENX is nominated with AGL and others for the best technology award in the AIM awards this year:hTTps://www.aim-awards.co.uk/nominations-overview/#nominations

[homebrewruss] 15/9/2021 10:00

The issue with these pre (significant) revenue companies is that the share price is particularly based on sentiment and once that's gone then a rapid fall can ensue. Hopefully we can now build a base around these levels as we await further news.

[nimbo1] 15/9/2021 09:35

I bought some 679, only small though so far.

[74tom] 15/9/2021 08:59

Had a feeling we'd see a fall like that, quite amazing how much panic can be created by something that nobody had even heard of before Jan 13th... We're back to solid support; £6.60 was reached just before the NASDAQ listing and was the level from which the price took off in Jan. A lot of progress has been made since and the risk reward now appears excellent pre FDA approval decision.

[mg1982] 15/9/2021 08:50

I have also topped up too now. Was getting jittery fingers but thanks TM and MGI

[toffeeman] 15/9/2021 08:49

gap filled - so I bought back at 660 - hope I got this right!!

[mginvestor] 15/9/2021 08:49

I've taken advantage of the dip

[wan] 15/9/2021 08:34

Verici and Renalytix has been nominated and shortlisted for the AIM Best Technology Award -

[toffeeman] 15/9/2021 08:29

There is a gap between about 650 to 680 in Jan 2021. I would expect this to fill.

[mysteronz] 14/9/2021 20:35

Good RNS ref MCIT, credit to RNLX for putting one out, would have preferred a pre US Open RNS if I was being picky.

[bertiebingo] 14/9/2021 17:50

Yes, this seems to be the main reason for the share price weakness although there's a delay for further review it could work to renalytix's advantage in the long run, assuming full suitability for medicare patients, etc. in retrospect the CMS/MCIT rule could have opened the floodgates to unsuitability, lawsuits.

[toffeeman] 14/9/2021 16:05

Crikey I could buy at 7.77.

I am assuming it is the short positions driving this down. Don't know where the bottom is.

Staying out for now

[mr roper] 14/9/2021 15:24

14m pa from this initial scale up from Mt sinai. 300pw x $950 x 50 weeks.

Conservatively assumed the same from the other 3 partnerships that have been signed to date to get 60m though they are larger than Mt sinai, hence up to 100m.

Excludes other partnerships. 2-3 to be signed before year end.
Excludes contribution from pharma.

[elsa7878] 14/9/2021 13:59

Not sure where you get your figures from but perhaps this sell off is simply that the share price got ahead of itself.

Forecasts are for $36 million in 2022 - that is revenues and burning $32 million, which after this years burn will leave them pretty low on cash.

So at £8 = approx 25 times next year's revenues.

My broker (one of the FTSE 100 ones) told me earlier this year to expect pre-profits of $25 million in 2024 or 2025...can't remember which.

If the share price stayed where it is now then that would be something like a 40 x post-tax multiple in 2024/2025.

I don't know enough but FWIW.

[sirshagalot] 14/9/2021 13:32

Yes looks good for rebound now a week early but so what.